Received Feb 24, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | — |
received first dose of a Kinrix vaccine to 4 year old patient; some of the vaccine was left inside the syringe; This non-serious case was reported by a other health professional via call center representative and described the occurrence of inappropriate schedule of vaccine administered in a 4-year-old patient who received DTPa-IPV (Kinrix) for prophylaxis. On an unknown date, the patient received the 1st dose of Kinrix. On an unknown date, an unknown time after receiving Kinrix, the patient experienced inappropriate schedule of vaccine administered (Verbatim: received first dose of a Kinrix vaccine to 4 year old patient) and incomplete dose administered (Verbatim: some of the vaccine was left inside the syringe). The outcome of the inappropriate schedule of vaccine administered and incomplete dose administered were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 20-FEB-2025 The reporter reported that the patient that was administered a 1st dose of Kinrix vaccine and some of the vaccine was left inside the syringe, which led to inappropriate schedule of vaccine administered and incomplete dose administered. The reporter asked if they have to revaccinate a four year old